LSV ASSET MANAGEMENT

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1050470 CHICAGO, IL

Position in HALO

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$88,643,793

+$1,082,792 QoQ

Shares Held

1,371,558

+5.4% QoQ

Ownership

1.16%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 47.16162203858678.ToString("F0")% Shared 0.ToString("F0")% None 52.83837796141323.ToString("F0")%

Healthcare · as of Mar 31, 2026

LSV ASSET MANAGEMENT holds $1,556,348,509 across 16 Biotechnology names. HALO ranks #5 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,386,840	$451,232,102
2	INCY	Incyte Corp	3,920,056	$368,955,670
3	EXEL	Exelixis, Inc.	7,745,715	$332,213,716
4	REGN	Regeneron Pharmaceuticals, Inc.	196,279	$151,653,006
5	HALO	Halozyme Therapeutics, Inc. This page	1,371,558	$88,643,793
6	HRMY	Harmony Biosciences Holdings, Inc.	2,025,143	$56,724,255
7	BMRN	Biomarin Pharmaceutical Inc	884,800	$49,982,352
8	RIGL	Rigel Pharmaceuticals Inc	601,507	$16,264,749

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$88,643,793	1,371,558	+5.4%	Shares	Sole	2026-05-11
2025-12-31	$87,561,001	1,301,055	+2.8%	Shares	Sole	2026-02-06
2025-09-30	$92,850,420	1,266,027	+0.9%	Shares	Sole	2025-11-06
2025-06-30	$65,297,584	1,255,240	+40.2%	Shares	Sole	2025-08-11
2025-03-31	$57,122,137	895,191	+41.9%	Shares	Sole	2025-05-09
2024-12-31	$30,171,026	631,061	+0.0%	Shares	Sole	2025-02-13
2024-09-30	$36,106,992	630,800	+2.8%	Shares	Sole	2024-11-12
2024-06-30	$32,138,568	613,800	+32.9%	Shares	Sole	2024-08-06
2024-03-31	$18,786,024	461,800	-0.1%	Shares	Sole	2024-05-06
2023-12-31	$17,090,304	462,400	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.